Medical Excellence Capital is an early stage life sciences fund.
Medical Excellence Capital is an early stage life sciences fund that combines a unique global network of physician scientists with a team of experienced investors, company builders, and operators.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Dec 5, 2022
SonoThera
|
Series A | $60.75M | Biopharma | — |
May 9, 2022
Aspen Neuroscience
|
Series B | $147.50M | Biotechnology | — |